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Abstract
Background: Xanthurenic acid is an endogenous molecule produced by tryptophan degradation,
produced in the cytoplasm and mitochondria. Its accumulation can be observed in aging-related
diseases, e.g. senile cataract and infectious disease. We previously reported that xanthurenic acid
provokes apoptosis, and now present a study of the response of mitochondria to xanthurenic acid.
Results: Xanthurenic acid at 10 or 20 µM in culture media of human aortic smooth muscle cells
induces translocation of the proteins Bax, Bak, Bclxs, and Bad into mitochondria. In 20 µM
xanthurenic acid, Bax is also translocated to the nucleus. In isolated mitochondria xanthurenic acid
leads to Bax and Bclxs oligomerization, accumulation of Ca2+, and increased oxygen consumption.
Conclusion: Xanthurenic acid interacts directly with Bcl-2 family proteins, inducing mitochondrial
pathways of apoptosis and impairing mitochondrial functions.
Background
Xanthurenic acid is an endogenous molecule derived
from tryptophan degradation by indoleamine-2, 3-dioxy-
genase. Indoleamine-2, 3-dioxygenase is induced in infec-
tious diseases by liposacharides, interferon-α, and
superoxide radicals [1]. Xanthurenic acid is enzymatically
formed by transamination of 3-hydroxykynurenine by
kynurenine-aminotransferase [2]. Kynurenine-ami-
notransferase, has been cloned from mitochondria and
cytoplasm [3,4]. Xanthurenic acid accumulates with age
in senile cataract [5-7]. Previously, we reported that this
acid leads to apoptotic-like cell death [8-10], its BH3
domain in the cytoplasm being responsible for targeting
the protein to mitochondria, resulting in cytochrome c
release [11,12]. We now report that proteins with a BH3-
domain (Bax, Bak, Bcl-xs, Bad) are transformed in the
presence of xanthurenic acid to their proapoptotic-induc-
ing state and translocated to mitochondria. In vitro, xan-
thurenic acid leads to covalent oligomerization of Bax,
and Bcl-xs. It also alters mitochondrial Ca2+ transport, and
increases oxygen consumption.
Results
Xanthurenic acid provokes translocation of Bak, Bax, 
Bclxs, and Bad to mitochondria
The fate of Bax, Bak, Bclxs, and Bad in cultures of aortic
human smooth muscle cells (HSMC) has been compared
with control cells, using the antibody against Bax, which
stains cells uniformly (Fig. 1A). 10 µM xanthurenic acid
results in Bax being translocated to mitochondria (Fig.
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1B), and at 20 µM, Bax seems to be translocated from
mitochondria to nuclei (Fig. 1C). However, at the latter
concentration, some Bax remained detectable in mito-
chondria (Fig. 1C). Granular bodies strongly staining with
anti-Bax antibodies (green) were detected in the nucleus
(Fig. 1C). Translocation of Bax to the nucleus during
apoptosis has previously been reported [13]. Proapoptotic
proteins Bak, Bclxs and Bad (Fig. 2A,2B,2C) at 10 and 20
µM xanthurenic acid (Fig. 2D,2E,2F) were translocated
into mitochondria.
Xanthurenic acid leads to oligomerization of cytoplasmic 
Bcl-xs and Bax in the rat liver mitochondrial fraction
Both Bcl-xs and Bax were found in the 10,000 g mitochon-
drial fraction of rat liver. When it was incubated with xan-
thurenic acid at 5–10 µM (1 mg of protein/ ml), cleavage
of Bax with formation of p18 was observed. Both anti-Bax
and anti-Bcl-xs recognized the N-terminal part of the pro-
teins, suggesting that the cleavage was more towards the
C-terminal domain. When the concentration of xan-
thurenic acid was increased to 20–40 µM (1 mg protein/
ml), Bax dimerized (Fig. 3A). Western blot analysis
showed an increase of staining and dimerization of Bcl-xs
in the presence of xanthurenic acid (Fig. 3B). In the mito-
chondrial fraction, incubation of Bcl-xs and Bax, with xan-
thurenic acid led to stronger attachment of the
correspondent IgG antibody than in control cells, indicat-
ing some form of posttranscriptional modification. Dim-
ers of the proapoptotic proteins in the presence of
xanthurenic acid showed up on SDS-PAGE, confirming
the formation of covalent crosslinking. Bax and Bclxs were
faintly detectable in the mitochondrial pellets. Cyto-
chrome c release was observed in the same protein extract
(Fig. 3C).
Mitochondrial Ca2+ release
Ca2+ release was measured with Arsenazo III at a wave-
length of 685/675 nm, using an Aminco DW-2 spectro-
photometer. Xanthurenic acid at 15 µM (1 mg protein/
ml) did not alter the release of Ca2+, but inhibition did
occur at 66 µM (1 mg protein/ml). Ca2+ retained in mito-
chondria at this concentration was liberated after addition
of 1 µM carbonyl cyanide-m-chlorophenylhydrazone
(CCCP), which is known to provoke a loss of potential
across mitochondrial membranes (Fig. 4). These results
indicate that xanthurenic acid is involved in the modifica-
tion of mitochondrial Ca2+ release, but does not lead to a
loss of the mitochondrial membrane potential.
Consumption of O2 by mitochondria in the presence of 
xanthurenic acid
Consumption of O2 was measured with a Clarke-type
electrode (Fig. 5). Mitochondrial respiration was sup-
ported with 2.5 mM potassium succinate prior to xan-
thurenic acid being added at 0.4 (Fig. 5, curve 1) or 4 µM
(Fig. 5, curve 2). Xanthurenic acid stimulated oxygen con-
sumption in a concentration-dependent manner.
Discussion
Apoptosis in the presence of xanthurenic acid is associated
with cytochrome c release [8-10]. Our investigations show
that xanthurenic acid induces the translocation of proap-
optotic Bcl-2 proteins to mitochondria. A posttranscrip-
tional modification of these proteins is suggested by the
Primary cell cultures human smooth muscle cells Figure 1
Primary cell cultures human smooth muscle cells (A-C, Bax): (A) in control cells (magnification 400×), (B) in the presence of 10 
µM xanthurenic acid (magnification 1260×), (C) in the presence of 20 µM xanthurenic acid (magnification 630×): mitochondria 
stained with MitotrackerRos (red staining), Bax (green), yellow-colocalization of Bax with mitochondria.BMC Cell Biology 2004, 5 http://www.biomedcentral.com/1471-2121/5/14
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direct crosslinking of Bax and Bcl-xs  in isolated
mitochondria. Previously, BID was reported to change the
conformation of Bax [14]. Recently, we reported that accu-
mulation of xanthurenic acid in cells interrupts the inter-
action of Bad with signalling proteins of the 14-3-3 family
[10]. However, here we have shown that Bax is dimerized
in isolated mitochondria, indicating that xanthurenic acid
itself induces a conformational change of the proteins.
Using Western blotting, Bax in mitochondria incubated
with xanthurenic acid was detected more readily than in
controls. This phenomenon was previously reported to
indicate a change in Bax folding which results in a better
exposition of the N-terminal part of Bax for the antibody
after exposure to apoptotic stimuli [15]. Furthermore,
xanthurenic acid appeared to modify the folding of pro-
teins [16], which could be the reason for the increased IgG
binding to proteins in the presence of xanthurenic acid.
Our results indicate that xanthurenic acid is an endog-
enous crosslinker of Bax and Bclxs proteins with a BH3
domain. Xanthurenic acid leads to translocation of BH3
proteins into mitochondria in human smooth muscle
aortic cells. However, in isolated mitochondria, dimerized
Bax and Bclxs found in the mitochondrial supernatant, are
almost undetectable in the pellets, indicating that an
additional cytoplasmic protein is necessary for transloca-
tion of these proteins into mitochondrial membranes.
Therefore, the observed cytochrome c release in the pres-
ence of xanthurenic acid in isolated mitochondria is not
mediated by Bax dimerization. At lower concentrations of
xanthurenic acid, cleavage of Bax produced p18, which
has been previously shown to enhance apoptosis [17].
Bax dimerization also has been shown to induce caspase-
independent cell death [18]. Xanthurenic acid at 20 µM
causes Bax translocation into the nucleus, and plays a key
role in apoptosis, because Bax/Bak deficient cells were
Primary cell cultures human smooth muscle cells Figure 2
Primary cell cultures human smooth muscle cells. (A-D, Bak): (A) Bak in control cells (magnification 800×) (D) Bak in presence 
of 20 µM xanthurenic acid (magnification 800×), (B-E, Bclxs): (B) Bclxs in control cells (magnification 1000×), (E) Bclxs in the 
presence of 10 µM xanthurenic acid (magnification 1260×), (C-F, Bad): (C) Bad in control cells (magnification 800×), (F) Bad 20 
µM xanthurenic acid (magnification 800×).BMC Cell Biology 2004, 5 http://www.biomedcentral.com/1471-2121/5/14
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resistant to the apoptotic stimuli staurosporine and
etoposide [19]. The fact that xanthurenic acid can directly
provoke Bax and Bcl-xs crosslinking suggests that an accu-
mulation of xanthurenic acid in a cell is sufficient to
induce the cell death. Xanthurenic acid might be oxidized
in vivo to its semiquinone, and further to quinone-di-oxo-
xanthurenic acid, as previously described [6]. The semiq-
uinone is an oxidative stress [20], which can lead to
uncoupling of mitochondria, characterized by an increase
of O2 consumption; in keeping, we noted an increased
consumption of O2 in the presence of xanthurenic acid.
Previously it was reported that Bax is only toxic in the
presence of active oxidative phosphorylation [21]. Our
results indicate that at 20 µM xanthurenic acid, Bax is
translocated into the nucleus and Ca2+ release from mito-
chondria is blocked. Xanthurenic acid accumulation in
mitochondria does not affect mitochondrial membrane
potential, because Ca2+ was accumulated in the mitochon-
dria and CCCP was able to release Ca2+ under these con-
ditions. Previously it was reported that Bax/Bax-induced
apoptosis was associated with an uptake of mitochondrial
Ca2+ by an unknown mechanism. An excessive Ca2+ load
may induce apoptosis by stimulating the release of apop-
tosis-promoting factors from the mitochondrial mem-
brane space to the cytoplasm, leading to impaired
mitochondrial function (for review [22]).
The results presented here indicate that the accumulation
of xanthurenic acid in the human aortic smooth muscle
cell causes a proapototic conformation of the mitochon-
drial proteins, Bax, Bak, Bcl-xs, and Bad. It was previously
reported, that mitochondrial Bax plays an essential role in
cytochrome c release, which can occur via Ca2+-dependent
and -independent mechanisms [23]. Bax-driven apoptosis
may be important for development of diabetes, athero-
sclerosis and neurological disorder [24-28]. We surmise
that an accumulation of the endogenous aromatic amine,
xanthurenic acid, may lead to organ failure.
Materials and methods
Reagents
The following polyclonal antibodies were obtained from
Santa Cruz Biotechnology Inc. CA, USA: antibody against
cytochrome c, against N-terminal part of Bax, Bak, Bcl-xs,
and Bad. IgG secondary antibodies–Texas Red conjugated
were from Santa Cruz or secondary antibodies IgG–Alexa
488 conjugated Molecular Probes (Leiden, The Nether-
lands). Carbonyl cyanide-m-chlorophenylhydrazone
(CCCP) and Arsenazo III were from Sigma.
Preparation of human smooth muscle cells primary culture
The normal human aortic smooth muscle cells were from
PromoCell GmbH, Heidelberg, Germany.
The cells were cultivated in Smooth Muscle Cells Growth
Medium 2 (SMCGM2) with an addition of Supplement
Pack/Smooth Muscle Cells (PromoCell). Cells were
grown under a humidified atmosphere of 5% CO2 in air
at 37°C. When confluent, they were incubated for 96
hours in the SMCGM2 or this medium supplemented
with 10 and 20 µM xanthurenic acid. A 20 mM stock solu-
tion of xanthurenic acid was prepared in 0.5 M NaHCO3,
and diluted in 0.01 M PBS pH 7.4.
Western blot analysis of protein from rat liver 
mitochondrial fraction
Rat liver mitochondria (80–90 mg protein per ml) were
isolated, as described previously [29]. The 10,000 g mito-
chondrial fraction of cells was used (referred herein as
mitochondria). The mitochondria were in MSH buffer
Western blot analysis of supernatant from rat liver mito- chondria incubated for 1 h in the presence of xanthurenic  acid for Bax, Bcl-xsand cytochrome c Figure 3
Western blot analysis of supernatant from rat liver mito-
chondria incubated for 1 h in the presence of xanthurenic 
acid for Bax, Bcl-xsand cytochrome c; (A-B) Western blot 
analysis of Bax and Bcl-xs: lane 1-control mitochondria; lanes 
2–5: mitochondria incubated in the presence of xanthurenic 
acid at concentration 5; 10; 20; and 40 µM per mg of protein 
(A) Bax; (B) Bcl-xs, (C) release of cytochrome c from mito-
chondria in the presence of xanthurenic acid at the same 
concentrations as in (A-B).BMC Cell Biology 2004, 5 http://www.biomedcentral.com/1471-2121/5/14
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(210 mM mannitol, 70 mM sucrose, 5 mM Hepes, pH
7.35 (4°C, 2 M KOH). Mitochondria (~3 mg protein per
100 µl of reaction mixture) were incubated for 1 h at room
temperature without xanthurenic acid or in the presence
of the increasing concentrations of xanthurenic acid from
5 to 40 µM per mg protein in the presence of the following
protease inhibitors: 0.1 mM phenyl-methylsulfonyl fluo-
ride, and leupeptin, aprotinin, and pepstatin, each at 1 µg/
ml. Thereafter, the sample was centrifuged for 10 min at
14,000 g, and the supernatant boiled in loading-buffer for
5 min. Proteins at 100 µg per lane were separated by SDS-
PAGE containing 12.5% acrylamide. After transfer to
Hybond ECL membrane (Amersham Pharmacia Biotech
AB, Uppsala, Sweden), the proteins were probed with the
appropriate antibodies. Chemiluminescence ECL system
(Amersham Pharmacia Biotech AB, Uppsala, Sweden) was
used for the detection of peroxidase-conjugated secondary
antibody.
Immunofluorescence studies
Cells grown on glass coverslips were fixed for 10 min at
room temperature in 4% paraformaldehyde in 0.1 M
PIPES, pH 6.8, washed in PBS and permeabilized for 5
min in PIPES containing 0.05% saponin (65 µl per
coverslip), washed in PBS, incubated for 10 min in cold
acetone for additional fixing and permeabilisation, and
again washed in PBS. Cells were incubated for 1.5 h with
the first antibody diluted in PBS containing 1% bovine
serum albumin, and after further washing incubated for
1.5 h with the secondary antibody. The coverslips were
washed in PBS and incubated for 10 min with 65 µl of
solution containing 1 µl of Hoechst 33342 dye (1 mg/ml),
washed in PBS, and incubated with Antifade Kits (Molec-
ular Probes, Leiden, The Netherlands) according to the
supplier's instruction.
Ca2+ release from mitochondria in the presence of xanthurenic acid Figure 4
Ca2+ release from mitochondria in the presence of xanthurenic acid (1) control mitochondria, (2, 3) in the presence of xan-
thurenic acid, and 1 mg of mitochondrial proteins: (2) 15 µM xanthurenic acid, (3) in the presence of 66 µM xanthurenic acid 
(4) after addition of CCCP to (3).BMC Cell Biology 2004, 5 http://www.biomedcentral.com/1471-2121/5/14
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Measurement of calcium uptake and release and O2 
consumption in liver mitochondria in the presence of 
xanthurenic acid
An Aminco DW-2A spectrophotometer was used at 685–
675 nm the presence of 50 µM Arzenazo III, and
mitochondrial respiration was measured using a Clarke-
electrode as described previously [29]. Briefly, mitochon-
dria (1 mg of mitochondrial protein/ml) were energized
with 2.5 mM potassium succinate in the presence of
rotenone. After Ca2+ uptake was complete, the uptake
blocker, ruthenium red (RR), was added to see net release
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